These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 8639781)

  • 1. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis.
    Furlan M; Robles R; Lämmle B
    Blood; 1996 May; 87(10):4223-34. PubMed ID: 8639781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein.
    He S; Cao H; Magnusson CG; Eriksson-Berg M; Mehrkash M; Schenck-Gustafsson K; Blombäck M
    Thromb Res; 2001 Aug; 103(3):241-8. PubMed ID: 11672586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion.
    Tsai HM
    Blood; 1996 May; 87(10):4235-44. PubMed ID: 8639782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF.
    Obert B; Tout H; Veyradier A; Fressinaud E; Meyer D; Girma JP
    Thromb Haemost; 1999 Nov; 82(5):1382-5. PubMed ID: 10595622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family.
    Fujikawa K; Suzuki H; McMullen B; Chung D
    Blood; 2001 Sep; 98(6):1662-6. PubMed ID: 11535495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Solenthaler M; Wassmer M; Sandoz P; Lämmle B
    Blood; 1997 May; 89(9):3097-103. PubMed ID: 9129011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial amino acid sequence of purified von Willebrand factor-cleaving protease.
    Gerritsen HE; Robles R; Lämmle B; Furlan M
    Blood; 2001 Sep; 98(6):1654-61. PubMed ID: 11535494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: inhibition by doxycycline and by monoclonal antibody VP-1.
    Tsai HM; Sussman II; Ginsburg D; Lankhof H; Sixma JJ; Nagel RL
    Blood; 1997 Mar; 89(6):1954-62. PubMed ID: 9058716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand factor: molecular size and functional activity.
    Furlan M
    Ann Hematol; 1996 Jun; 72(6):341-8. PubMed ID: 8767102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.
    Chung MC; Popova TG; Jorgensen SC; Dong L; Chandhoke V; Bailey CL; Popov SG
    J Biol Chem; 2008 Apr; 283(15):9531-42. PubMed ID: 18263586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of chloride ions in modulation of the interaction between von Willebrand factor and ADAMTS-13.
    De Cristofaro R; Peyvandi F; Palla R; Lavoretano S; Lombardi R; Merati G; Romitelli F; Di Stasio E; Mannucci PM
    J Biol Chem; 2005 Jun; 280(24):23295-302. PubMed ID: 15809291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome.
    Fujimura Y; Matsumoto M; Yagi H; Yoshioka A; Matsui T; Titani K
    Int J Hematol; 2002 Jan; 75(1):25-34. PubMed ID: 11843286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of a rapid method using agarose gel electrophoresis and Western blotting to evaluate von Willebrand factor protease activity.
    Kirzek DM; Rick ME
    Electrophoresis; 2001 Mar; 22(5):946-9. PubMed ID: 11332762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13).
    Plaimauer B; Zimmermann K; Völkel D; Antoine G; Kerschbaumer R; Jenab P; Furlan M; Gerritsen H; Lämmle B; Schwarz HP; Scheiflinger F
    Blood; 2002 Nov; 100(10):3626-32. PubMed ID: 12393399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of human von Willebrand factor by platelet calcium-activated protease.
    Kunicki TJ; Montgomery RR; Schullek J
    Blood; 1985 Feb; 65(2):352-6. PubMed ID: 2981585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13.
    Kokame K; Matsumoto M; Fujimura Y; Miyata T
    Blood; 2004 Jan; 103(2):607-12. PubMed ID: 14512308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substructure of human von Willebrand factor. Proteolysis by V8 and characterization of two functional domains.
    Fretto LJ; Fowler WE; McCaslin DR; Erickson HP; McKee PA
    J Biol Chem; 1986 Nov; 261(33):15679-89. PubMed ID: 3536910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased levels of von Willebrand factor-cleaving protease in coronary heart disease and thrombotic thrombocytopenic purpura: study of a simplified method for assaying the enzyme activity based on ristocetin-induced platelet aggregation.
    Yoo G; Blombäck M; Schenck-Gustafsson K; He S
    Br J Haematol; 2003 Apr; 121(1):123-9. PubMed ID: 12670342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.